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WHAT IS BIOINFORMATICS AND HOW IS IT APPLIED?
The future is the widespread application of technologies that currently exist but are restricted. For example, the first email was sent in 1971 between two physically adjacent computers. However, this technology only has an impact when there are large numbers of people with email addresses, who care to read email, and with ready access to hardware and software to run email programs. In short, the world of 1971 in Europe and North America was vastly different to today. One year earlier, in 1970, Paulien Hogeweg and Ben Hesper developed the term bioinformatics to refer to the study in biological systems of how information was encoded and determined cell development (reviewed in (Hogeweg, 2011) ). In this manner Hogeweg and Hesper considered bioinformatics as the study of information in biology, thereby akin to biochemistry, or the study of chemistry in biology.
The roots of bioinformatics encapsulate theory and approaches that in many cases were themselves already well-established. In much the same way that it took nearly half a century for the digital age to prevail, the wider application of bioinformatic approaches required progress in other disciplines accompanied by development of companion practices and technologies. For example, the further development of computational theory and computational hardware, as well as the development of statistical concepts were all absolutely necessary for the widespread application of bioinformatics. In short, the central components of bioinformatics are the statistical and computational sciences, which each have their own considerable histories. Bioinformatics is therefore a truly interdisciplinary approach with high transformative potential.
Currently, it isn't clear how the biological community stands in terms of the widespread application of bioinformatics. In terms of the email analogy, there are significant M A N U S C R I P T
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5 bioinformatics will be democratized within 50 years of its conception, a time point that is only a few years away from the time of writing in 2017. Instead it remains a fairly restrictive practice. Arguably, this is deleterious for the biological and biomedical communities and needs to be addressed strategically, and urgently.
2. BIOINFORMATICS APPROACHES CAN IDENTIFY GENOME-WIDE
SIGNIFICANT RELATIONSHIPS FOR THE VDR; THE 20,000-FOOT VIEW.
The goal of bioinformatics is to reveal novel biological understanding. The premise for such analyses is that the comprehensive analyses of biological data, free from a bias as to what are the major biological drivers of a given phenotype, will reveal organizational insight that is neither obvious nor intuitive. In this respect, analyses that has no assumptions what are the biological drivers of a given phenotype can be achieved by applying algorithmic approaches that depend on discrete mathematics and information theory, combined with graph theory, data mining, computer science generally, with a central role for the statistical sciences. In this manner, bioinformatic approaches offer the promise to reveal underlying mechanisms of biology in health and disease.
Importantly, such approaches hold the promise of revealing insight that is unlikely to be revealed by reductionist experimental approaches.
However, here a note of caution should also be considered. No analyses is free from bias. That is, many of the algorithms and statistical approaches applied, for example to next-generation sequencing approaches, themselves are built on certain assumptions on the distribution of the data and how in broad terms significance can be determined.
In this regard, it is possible that a certain analytical workflow may contain certain biases as to how the biological material is captured, analyzed and interpreted. For example, a trivial example would emerge over considering how degradation rates of nucleic acid material could impact library preparation and how signal is considered significant(van Several points are worth stressing from this theoretical workflow. Firstly, study design in terms of replicates and time points applied to the appropriate cell phenotype description are both critical. Secondly, all analyses include a denominator (e.g. the genome, the detectable transcriptome etc) such that any change is considered against the backdrop of all events occurring in the cell. Thirdly, all data processing includes normalization across samples, including replicates and states, and subsequent filtering to remove the large component of the signal that is unchanging, and therefore limit the penalties of false discovery. Finally, the integrative steps have very high potential for creativity and novelty. That is, as the volume of publically available data grow, the statistical approaches and types of data integration that can occur are varied and represent where many of the key biological questions of the future will be framed. In contrast, in part because molecular biology has become so widely democratized, the wet lab component in this workflow has less potential for creativity and novelty.
The mechanics of VDR signaling is well-studied in both humans and genetic mouse models, and therefore extensively reviewed (Campbell, 2014 
). Therefore, the current review will focus on the application of bioinformatics approaches applied to place VDR signaling in an integrated context.
There are several different ways in which bioinformatics approaches could be applied to VDR. In the first instance, a strict interpretation can be applied whereby the question addressed is to consider where VDR biology been identified as significant following bioinformatics analyses that considers the genome as the denominator for analyses.
The null hypothesis in this approach is that the VDR is not biologically significant and empiric bias doesn't impact either study design or analytical workflow. 16 were designed to test the null hypothesis that could be used to determine where a significant role for VDR expression or function emerges in one of these 10 phenotypes.
The other 55 publications were biased in the sense that the system examined was either treated with vitamin D ligands, of examined the impact of changing VDR expression, for example in a knockout mouse model. In this manner these publications all took the a priori assumption that the VDR was biologically significant.
Publications that reported genetic variation and could reveal a genome-wide significant role for the VDR was also searched. In the same manner, 2142 publications have aimed to identify roles for significant genetic variation associated with the ten phenotypes examined. Of these, 2 publications directly identified a genome-wide significant role for
genetic variation associated with the VDR with one of the 10 phenotypes, specifically altered metabolism. In parallel, the GWAS catalog was mined with the term VDR and a further 3 publications were identified that annotated significant genetic variation to the VDR gene that associated with immunity, reproduction or diabetes.
In total, therefore, 21 papers, from 53791 (0.039%) phenotype-associated studies that applied bioinformatics analyses identified a genome-wide significant relationship between VDR function and one of the phenotypes.
There are a number of caveats to these literature mining. The scientific literature is itself biased. There are approximately 5000 papers that consider the VDR and ten times as many that examine the androgen receptor (AR), and 1/100 as many that consider NR6A1. It is not possible to know if this is biologically based. Is the AR ten times more important in some biological sense than the VDR; is a man suffering from advanced prostate cancer more important than a child suffering with rickets? Similarly, in the arena of genetic variation, as data sets increase in size, and with more defined phenotypes, rare variants may emerge associated with the VDR. However, with over 5000 papers the VDR is fairly well studied, and it is possible to begin to infer where its actions are biologically-significant at the genome-wide level. possibility. It could be argued that the ongoing analyses of the literature in this manner could be used to direct where research efforts can be most readily justified. Given the ever increasing costs of biomedical research, it is perhaps reasonable that such literature mining that identifies genome-wide significant association of the VDR with a given phenotype may lead to more impactful research findings.
BIOINFORMATIC APPROACHES TO VDR SIGNALING EVENTS; THE 2,000-FOOT VIEW.
Alternative approaches to apply bioinformatic insight to dissecting VDR function are to adjust the denominator. For example, to consider VDR status compared only to a smaller sub-set of related genes or proteins, and to consider only the down-stream consequences of VDR, and then to apply unbiased approaches. This approach then is a mixture of biased and unbiased approaches. It starts with the premise that the VDR is significant in a given phenotype, and then tests the null hypothesis that VDR does not regulate genes significantly that are associated with a given phenotype. In this manner 
VDR analyses at the genomic level
Arguably, VDR ChIP-seq studies are more important than transcriptomic studies as they reveal direct VDR genomic interactions, whereas transcriptomic analyses inevitably In this context, murine models of VDR action can be highly informative. For example, by focusing on biological settings where the VDR is known to play a significant role, these can be extensively analyzed in a manner that is challenging to achieve human cell 
SUMMARY
Bioinformatics approaches aim to apply comprehensive statistical approaches to biological systems and to reveal novel insight. Given the high quality publically available data that is ever increasing in volume, it is timely for investigators to use these approaches to address questions concerning VDR function in health and disease.
Currently, at the 20,000 ft view that considers the genome-wide level, significant roles for the VDR are identified in the regulation of the calcium signaling in bone phenotypes as well as being clearly implicated in immune system. From this perspective and with current methodologies it is harder to make a case that the VDR itself, either through loss or gain of function, is a cancer-driver or is strongly related to other phenotypes such as nutrition and diabetes. [9] Nakou, M., Bertsias, G., Stagakis, I., Centola, M., Tassiulas, I., Hatziapostolou, M., Kritikos, I., Goulielmos, G., Boumpas, D.T. and Iliopoulos, D., 2010. Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus, PLoS One. 5, e13351.
[10] Fowlkes, J.L., Bunn, R.C., Liu, L., Wahl, E.C., Coleman, H.N., Cockrell, G.E., Perrien, D.S., Lumpkin, C.K., Jr. and Thrailkill, K.M., 2008. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus, Endocrinology. 149, 1697-704. [17] Wang, J., Thingholm, L.B., Skieceviciene, J., Rausch, P., Kummen, M., Hov, J.R., Degenhardt, F., Heinsen, F.A., Ruhlemann, M.C., Szymczak, S., Holm, K., Esko, T., Sun, J., Pricop-Jeckstadt, M., AlDury, S., Bohov, P., Bethune, J., Sommer, F., Ellinghaus, D., Berge, R.K., Hubenthal, M., Koch, M., Schwarz, K., Rimbach, G., Hubbe, P., Pan, W.H., Sheibani-Tezerji, R., Hasler, R., Rosenstiel, P., D'Amato, M., Cloppenborg-Schmidt, K., Kunzel, S., Laudes, M., Marschall, H.U., Lieb, W., Nothlings, U., Karlsen, T.H., Baines, J. • Contemporary bioinformatic approaches have a 50 year history and have the potential to reveal insight and understanding in biology that cannot be achieved with reductionist experimental approaches.
• Bioinformatic approaches towards understanding the VDR can be applied genome-wide, at the 20,000 ft view, or in a more conditional 2,000 ft view centered around the VDR.
• Genome-wide approaches highlight the role for VDR to impact bone biology and immune function, but offer less support for a significant role in cancer biology.
• Conditional approaches reveal key signaling pathways that are governed by the VDR and highlight roles for cross-talk with other transcription factors such as NF-κB and related immune phenotypes.
• The ever increasing volume of genomic data matched by development of bioinformatic analytical approaches is establishing a very large range of data integration possibilities to establish a more nuanced understanding of VDRgenome interactions and their relationship to health and disease.
